Nanotechnology for protein delivery: Overview and perspectives
Open accessAbstract
Protein-based therapeutics have made a significant impact in the treatment of a variety of important human diseases. However, given their intrinsically vulnerable structure and susceptibility to enzymatic degradation, many therapeutic proteins such as enzymes, growth factors, hormones, and cytokines suffer from poor physicochemical/biological stability and immunogenicity that may limit their potential benefits, and in some cases limit their utility. Furthermore, when protein therapeutics are developed for intracellular targets, their internalization and biological activity may be limited by inefficient membrane permeability and/or endosomal escape. Development of effective protein delivery strategies is therefore essential to further enhance therapeutic outcomes to enable widespread medical applications. This review discusses the advantages and limitations of marketed and developmental-stage protein delivery strategies, and provides a focused overview of recent advances in nanotechnology platforms for the systemic delivery of therapeutic proteins. In addition, we also highlight nanoparticle-mediated non-invasive administration approaches (e.g., oral, nasal, pulmonary, and transdermal routes) for protein delivery.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Delivery of proteins such as catalase raises concerns of instability in vivo due to physiological proteases, unpredictable protein immunogenicity, and poor in vivo half-life.
“Delivery of proteins such as catalase raises a few concerns such as its instability in vivo due to the presence of numerous physiological proteases, unpredictable protein immunogenicity, and poor in vivo half-life.27,28”
From Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor (2019) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710 · see citing works
Self-citationPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,970 · see citing works
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282 · see citing works
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893 · see citing works
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,519 · see citing works
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,924 · see citing works
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,865 · see citing works
Self-citationGold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, É., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,832 · see citing works
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J. M., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,685 · see citing works
Self-citationPolymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633 · see citing works
Cancer immunotherapy via dendritic cells
Palucka, K., & Banchereau, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3258 · Cited by 2,060 · see citing works
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 1,913 · see citing works
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic‐Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,734 · see citing works
Self-citationActive targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon‐Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,732 · see citing works
Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies
Mitragotri, S., Burke, P. A., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4363 · Cited by 1,702 · see citing works
Vertebrate protein glycosylation: diversity, synthesis and function
Moremen, K. W., Tiemeyer, M., & Nairn, A. V. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3383 · Cited by 1,681 · see citing works
Magnetic nanoparticles for drug delivery
Arruebo, M., Fernández‐Pacheco, R., Ibarra, M. R., & Santamarı́a, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,630 · see citing works
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605 · see citing works
Pharmacokinetics and Biodistribution of Nanoparticles
Li, S., & Huang, L. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800049w · Cited by 1,570 · see citing works
Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities
Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900441 · Cited by 1,320 · see citing works
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Jain, R. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.3653 · Cited by 1,248 · see citing works
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics
Akinc, A., Zumbuehl, A., Goldberg, M. S., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S., Nguyen, D. N., Fuller, J. E., Alvarez, R., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1402 · Cited by 1,228 · see citing works
Large Porous Particles for Pulmonary Drug Delivery
Edwards, D. A., Hanes, J. S., Caponetti, G., Hrkach, J. S., Ben-Jebria, A., Eskew, M. L., Mintzes, J. D., Deaver, D. R., Lotan, N., & Langer, R. (1997) · Science · doi:10.1126/science.276.5320.1868 · Cited by 1,176 · see citing works
Chauhan, V. P., Stylianopoulos, T., Martin, J. D., Popović, Z., Chen, O., Kamoun, W. S., Bawendi, M. G., Fukumura, D., & Jain, R. K. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.45 · Cited by 1,101 · see citing works
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088 · cited 2× · see citing works
“Since the first nanotherapeutic Doxil (pegylated liposomal doxorubicin) received FDA approval in 1995, the pipeline of nanomedicines for the management of various diseases has greatly expanded [9, 136].”
BackgroundLipid-Based Nanoparticles as Pharmaceutical Drug Carriers: From Concepts to Clinic
Puri, A., Loomis, K. H., Smith, B. J., Lee, J. H., Yavlovich, A., Heldman, E., & Blumenthal, R. P. (2009) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v26.i6.10 · Cited by 1,075 · see citing works
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025 · see citing works
Minimal "Self" Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Rodriguez, P. L., Harada, T., Christian, D. A., Pantano, D. A., Tsai, R. K., & Discher, D. E. (2013) · Science · doi:10.1126/science.1229568 · Cited by 986 · see citing works
Targeting nanoparticles to cancer
Wang, M., & Thanou, M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.005 · Cited by 928 · see citing works
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 884 · see citing works
Self-citationYu, J., Zhang, Y., Ye, Y., DiSanto, R., Sun, W., Ranson, D., Ligler, F. S., Buse, J. B., & Gu, Z. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505405112 · Cited by 852 · see citing works
Strategies for advancing cancer nanomedicine
Chauhan, V. P., & Jain, R. K. (2013) · Nature Materials · doi:10.1038/nmat3792 · Cited by 815 · see citing works
Biodegradable microspheres for protein delivery
Sinha, V. R., & Trehan, A. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00194-9 · Cited by 815 · see citing works
Design considerations for tumour-targeted nanoparticles
Choi, H. S., Liu, W., Liu, F., Nasr, K., Misra, P., Bawendi, M. G., & Frangioni, J. V. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2009.314 · Cited by 754 · see citing works
Parameters influencing the stealthiness of colloidal drug delivery systems
Vonarbourg, A., Passirani, C., Saulnier, P., & Benoit, J.-P. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.039 · Cited by 740 · see citing works
Chen, Y., Chen, H., & Shi, J. (2013) · Advanced Materials · doi:10.1002/adma.201205292 · Cited by 726 · see citing works
Self-citationTransport of drugs across the blood–brain barrier by nanoparticles.
Wohlfart, S., Gelperina, S., & Kreuter, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.017 · Cited by 715 · see citing works
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A. Z., Radovic‐Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 714 · see citing works
Self-citationChitosan-based delivery systems for protein therapeutics and antigens
Amidi, M., Mastrobattista, E., Jiskoot, W., & Hennink, W. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.009 · Cited by 622 · see citing works
Managing diabetes with nanomedicine: challenges and opportunities
Omid Veiseh, A., Tang, B. C., Whitehead, K. A., Anderson, D. G., & Langer, R. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4477 · Cited by 618 · see citing works
Engineering synthetic vaccines using cues from natural immunity
Irvine, D. J., Swartz, M. A., & Szeto, G. L. (2013) · Nature Materials · doi:10.1038/nmat3775 · Cited by 596 · see citing works
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Um, S. H., Khant, H. A., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564 · see citing works
Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging
Park, J., von Maltzahn, G., Zhang, L., Schwartz, M. P., Ruoslahti, E. I., Bhatia, S. N., & Sailor, M. J. (2008) · Advanced Materials · doi:10.1002/adma.200800004 · Cited by 557 · see citing works
How Tolerogenic Dendritic Cells Induce Regulatory T Cells
Maldonado, R., & von Andrian, U. H. (2010) · Advances in immunology · doi:10.1016/b978-0-12-380995-7.00004-5 · Cited by 543 · see citing works
Tailoring nanocarriers for intracellular protein delivery
Gu, Z., Biswas, A., Zhao, M., & Tang, Y. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00227e · Cited by 543 · see citing works
Delivery of Therapeutic Proteins
Pisal, D. S., Kosloski, M. P., & Balu-Iyer, S. V. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22054 · Cited by 532 · see citing works
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521 · see citing works
Park, J. Y., Wrzesinski, S. H., Stern, E., Look, M., Criscione, J. M., Ragheb, R. R. T., Jay, S. M., Demento, S. L., Agawu, A., Licona-Limón, P., et al. (2012) · Nature Materials · doi:10.1038/nmat3355 · Cited by 490 · see citing works
Fc‐fusion proteins: new developments and future perspectives
Czajkowsky, D. M., Hu, J., Shao, Z., & Pleass, R. J. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201379 · Cited by 477 · see citing works
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Shi, J., Xiao, Z., Kamaly, N., & Farokhzad, O. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar200054n · Cited by 476 · see citing works
Self-citationNanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines
Nochi, T., Yuki, Y., Takahashi, H., Sawada, S., Mejima, M., Kohda, T., Harada, N., Kong, I. G., Sato, A., Kataoka, N., et al. (2010) · Nature Materials · doi:10.1038/nmat2784 · Cited by 469 · see citing works
Injectable Nano-Network for Glucose-Mediated Insulin Delivery
Gu, Z., Aimetti, A. A., Wang, Q., Dang, T. T., Zhang, Y., Omid Veiseh, A., Cheng, H., Langer, R., & Anderson, D. G. (2013) · ACS Nano · doi:10.1021/nn400630x · Cited by 463 · see citing works
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Schellenberger, V., Wang, C., Geething, N. C., Spink, B. J., Campbell, A., To, W., Scholle, M. D., Yin, Y., Yao, Y., Bogin, O., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1588 · Cited by 462 · see citing works
Cell-penetrating and cell-targeting peptides in drug delivery
Vivès, É., Schmidt, J., & Pèlegrin, A. (2008) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.03.001 · Cited by 442 · see citing works
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Maldonado, R. A., LaMothe, R. A., Ferrari, J. D., Zhang, A.-H., Rossi, R. J., Kolte, P. N., Griset, A. P., O’Neil, C., Altreuter, D. H., Browning, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408686111 · Cited by 441 · see citing works
Self-citationCell Penetrating Peptides: Intracellular Pathways and Pharmaceutical Perspectives
Patel, L. N., Zaro, J. L., & Shen, W. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9303-7 · Cited by 426 · see citing works
A novel intracellular protein delivery platform based on single-protein nanocapsules
Yan, M., Du, J., Gu, Z., Liang, M., Hu, Y., Zhang, W., Priceman, S. J., Wu, L., Zhou, Z. H., Liu, Z., et al. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.341 · Cited by 424 · see citing works
Perspectives and opportunities for nanomedicine in the management of atherosclerosis
Lobatto, M. E., Fuster, V., Fayad, Z. A., & Mulder, W. J. M. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3578 · Cited by 423 · see citing works
Transepithelial Transport of Fc-Targeted Nanoparticles by the Neonatal Fc Receptor for Oral Delivery
Pridgen, E. M., Alexis, F., Kuo, T. T., Levy‐Nissenbaum, E., Karnik, R., Blumberg, R. S., Langer, R., & Farokhzad, O. C. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007049 · Cited by 408 · see citing works
Self-citationShan, W., Zhu, X. D., Liu, M., Li, L., Zhong, J., Sun, W., Zhang, Z., & Huang, Y. (2015) · ACS Nano · doi:10.1021/acsnano.5b00028 · Cited by 395 · see citing works
The two faces of protein misfolding: gain‐ and loss‐of‐function in neurodegenerative diseases
Winklhofer, K. F., Tatzelt, J., & Haass, C. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601930 · Cited by 395 · see citing works
Issues in long-term protein delivery using biodegradable microparticles
Ye, M., Kim, S., & Park, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.011 · Cited by 386 · see citing works
The coming of age of virus-like particle vaccines
Jennings, G. T., & Bachmann, M. F. (2008) · Biological Chemistry · doi:10.1515/bc.2008.064 · Cited by 373 · see citing works
Haschek and Rousseaux's Handbook of Toxicologic Pathology
Haschek, W. M., Rousseaux, C. G., & Wallig, M. A. (2013) · Elsevier eBooks · doi:10.1016/c2010-1-67850-9 · Cited by 353 · see citing works
Flögel, U., Ding, Z., Hardung, H., Jander, S., Reichmann, G., Jacoby, C., Schubert, R., & Schrader, J. (2008) · Circulation · doi:10.1161/circulationaha.107.737890 · Cited by 350 · see citing works
Batchelor, T. T., Gerstner, E. R., Emblem, K. E., Duda, D. G., Kalpathy–Cramer, J., Snuderl, M., Ancukiewicz, M., Polaskova, P., Pinho, M. C., Jennings, D. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318022110 · Cited by 343 · see citing works
Nanoparticle-detained toxins for safe and effective vaccination
Hu, C. J., Fang, R. H., Luk, B. T., & Zhang, L. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2013.254 · Cited by 342 · see citing works
Design and Chemical Synthesis of a Homogeneous Polymer-Modified Erythropoiesis Protein
Kochendoerfer, G. G., Chen, S.-Y., Mao, F., Cressman, S., Traviglia, S. L., Shao, H., Hunter, C. L., Low, D. W., Cagle, E. N., Carnevali, M., et al. (2003) · Science · doi:10.1126/science.1079085 · Cited by 312 · see citing works
Targeted gene knockout by direct delivery of zinc-finger nuclease proteins
Gaj, T., Guo, J., Kato, Y., Sirk, S. J., & Barbas, C. F. (2012) · Nature Methods · doi:10.1038/nmeth.2030 · Cited by 306 · see citing works
Wilson, J. T., Keller, S., Manganiello, M. J., Cheng, C., Lee, C.-C., Opara, C. C., Convertine, A. J., & Stayton, P. (2013) · ACS Nano · doi:10.1021/nn305466z · Cited by 294 · see citing works
Sonaje, K., Chen, Y., Chen, H., Wey, S., Juang, J., Nguyen, H.-N., Hsu, C., Lin, K., & Sung, H. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.042 · Cited by 282 · see citing works
Patel, Z. S., Yamamoto, M., Ueda, H. R., Tabata, Y., & Mikos, A. G. (2008) · Acta Biomaterialia · doi:10.1016/j.actbio.2008.04.002 · Cited by 278 · see citing works
Hong, R., Fischer, N. O., Verma, A., Goodman, C. M., Emrick, T. S., & Rotello, V. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja037470o · Cited by 273 · see citing works
Shang, L., Bian, T., Zhang, B., Zhang, D., Wu, L., Tung, C., Yin, Y., & Zhang, T. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201310508 · Cited by 255 · see citing works
Salvador-Morales, C., Zhang, L., Langer, R., & Farokhzad, O. C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.005 · Cited by 251 · see citing works
Self-citationWang, M., Alberti, K. A., Sun, S., Arellano, C. L., & Xu, Q. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311245 · Cited by 250 · see citing works
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes
Rosenstock, J., Reusch, J. E. B., Bush, M., Yang, F., Stewart, M. W., & for the Albiglutide Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0366 · Cited by 237 · see citing works
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
Sockolosky, J. T., & Szoka, F. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.02.005 · Cited by 237 · see citing works
Bitonti, A. J., Dumont, J. A., Low, S. C., Peters, R., Kropp, K. E., Palombella, V. J., Stattel, J. M., Lu, Y., Tan, C. A., Song, J. J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403235101 · Cited by 234 · see citing works
Jiang, T., Sun, W., Zhu, Q., Burns, N. A., Khan, S. A., Mo, R., & Gu, Z. (2014) · Advanced Materials · doi:10.1002/adma.201404498 · Cited by 228 · see citing works
Estey, T., Kang, J., Schwendeman, S. P., & Carpenter, J. F. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20625 · Cited by 221 · see citing works
Protein delivery using engineered virus-like particles
Kaczmarczyk, S. J., Sitaraman, K., Young, H. A., Hughes, S. H., & Chatterjee, D. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101874108 · Cited by 220 · see citing works
Therapeutic antibodies: past, present and future
Leavy, O. (2010) · Nature reviews. Immunology · doi:10.1038/nri2763 · Cited by 216 · see citing works
DeMuth, P. C., Moon, J. J., Suh, H., Hammond, P. T., & Irvine, D. J. (2012) · ACS Nano · doi:10.1021/nn302639r · Cited by 195 · see citing works
Fc fusion as a platform technology: potential for modulating immunogenicity
Levin, D., Golding, B., Strome, S. E., & Sauna, Z. E. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.11.001 · Cited by 192 · see citing works
Ghosh, P., Yang, X., Arvizo, R. R., Zhu, Z., Agasti, S. S., Mo, Z., & Rotello, V. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja907887z · Cited by 192 · see citing works
Tang, R., Kim, C. S., Solfiell, D. J., Rana, S., Mout, R., Velázquez-Delgado, E. M., Chompoosor, A., Jeong, Y., Yan, B., Zhu, Z.-J., et al. (2013) · ACS Nano · doi:10.1021/nn402753y · Cited by 188 · see citing works
Li, A. V., Moon, J. J., Abraham, W. D., Suh, H., Elkhader, J. A., Seidman, M. A., Yen, M., Im, E., Foley, M. H., Barouch, D. H., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006516 · Cited by 187 · see citing works
Applications of inorganic nanoparticles as therapeutic agents
Kim, T., & Hyeon, T. (2013) · Nanotechnology · doi:10.1088/0957-4484/25/1/012001 · Cited by 181 · see citing works
Thornton, E. E., Looney, M. R., Bose, O., Sen, D., Sheppard, D., Locksley, R. M., Huang, X., & Krummel, M. F. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112667 · Cited by 179 · see citing works
Targeted Delivery of Nanoparticles to Ischemic Muscle for Imaging and Therapeutic Angiogenesis
Kim, J., Cao, L., Shvartsman, D., Silva, E. A., & Mooney, D. J. (2011) · Nano Letters · doi:10.1021/nl103812a · Cited by 150 · see citing works
Low‐Density Lipoprotein Receptor on Endothelium of Brain Capillaries
Méresse, S., Delbart, C., Fruchart, J., & Cecchelli, R. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07340.x · Cited by 143 · see citing works
Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers
Wu, J., Kamaly, N., Shi, J., Zhao, L., Xiao, Z., Hollett, G., John, R. A., Ray, S., Xu, X., Zhang, X., et al. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201404766 · Cited by 141 · see citing works
Self-citationKim, S. K., Foote, M. B., & Huang, L. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.02.010 · Cited by 136 · see citing works
Iordanov, M. S., Ryabinina, O. P., Wong, J., Dinh, T.-H., Newton, D. L., Rybak, S. M., & Magun, B. E. (2000) · PubMed · Cited by 131 · see citing works
Functional Protein Delivery into Neurons Using Polymeric Nanoparticles
Hasadsri, L., Kreuter, J., Hattori, H., Iwasaki, T., & George, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805956200 · Cited by 127 · see citing works
Cell Penetrating Peptides in the Delivery of Biopharmaceuticals
Munyendo, W. L. L., Lv, H., Benza-Ingoula, H., Baraza, L. D., & Zhou, J. (2012) · Biomolecules · doi:10.3390/biom2020187 · Cited by 124 · see citing works
Yoshizaki, Y., Yuba, E., Sakaguchi, N., Koiwai, K., Harada, A., & Kono, K. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.05.077 · Cited by 121 · see citing works
Morlock, M. M., Kissel, T., Li, Y. X., Koll, H., & Winter, G. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00070-4 · Cited by 112 · see citing works
Xiao, C., Ding, J., Ma, L., Yang, C., Zhuang, X., & Chen, X. (2014) · Polymer Chemistry · doi:10.1039/c4py01156b · Cited by 112 · see citing works
Site-specific PEGylation of Proteins: Recent Developments
Nischan, N., & Hackenberger, C. P. R. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo502136n · Cited by 109 · see citing works
Efficient skin permeation of soluble proteins via flexible and functional nano-carrier
Choi, W. I., Lee, J., Kim, J., Kim, J., Kim, Y., & Tae, G. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.013 · Cited by 107 · see citing works
Lipid-based systems for the enhanced delivery of poorly water soluble drugs
Porter, C. J. H., Wasan, K. M., & Constantinides, P. P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.10.009 · Cited by 99 · see citing works
Direct cellular delivery of human proteasomes to delay tau aggregation
Han, D. H., Na, H., Choi, W. H., Lee, J. H., Kim, Y. K., Won, C., Lee, S., Kim, K. P., Kuret, J., Min, D., et al. (2014) · Nature Communications · doi:10.1038/ncomms6633 · Cited by 97 · see citing works
Ramqvist, T., Andreasson, K., & Dalianis, T. (2007) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.7.997 · Cited by 94 · see citing works
Micro/Nanostructured Polymeric Systems for Biomedical and Pharmaceutical Applications
Chiellini, E., Piras, A. M., Errico, C., & Chiellini, E. (2008) · Nanomedicine · doi:10.2217/17435889.3.3.367 · Cited by 94 · see citing works
Fast, J. L., Cordes, A. A., Carpenter, J. F., & Randolph, T. W. (2009) · Biochemistry · doi:10.1021/bi900853v · Cited by 92 · see citing works
Zhao, M., Hu, B., Gu, Z., Joo, K., Wang, P., & Tang, Y. (2013) · Nano Today · doi:10.1016/j.nantod.2012.12.003 · Cited by 88 · see citing works
Keijzer, C., Slütter, B., van der Zee, R., Jiskoot, W., van Eden, W., & Broere, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026684 · Cited by 87 · see citing works
FcRn: From Molecular Interactions to Regulation of IgG Pharmacokinetics and Functions
Challa, D. K., Velmurugan, R., Ober, R. J., & Ward, E. S. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-07911-0_12 · Cited by 84 · see citing works
Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin
Builders, P. F., Kunle, O. O., Okpaku, L. C., Builders, M. I., Attama, A. A., & Adikwu, M. U. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.021 · Cited by 79 · see citing works
Protein transduction domains: are they delivering?
Green, I., Christison, R., Voyce, C. J., Bundell, K. R., & Lindsay, M. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(03)00076-2 · Cited by 78 · see citing works
Targeting FcαRI on Polymorphonuclear Cells Induces Tumor Cell Killing through Autophagy
Bakema, J. E., Ganzevles, S. H., Fluitsma, D. M., Schilham, M. W., Beelen, R. H. J., Valerius, T., Lohse, S., Glennie, M. J., Medema, J. P., & van Egmond, M. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002581 · Cited by 76 · see citing works
Transdermal permeation enhancement of N-trimethyl chitosan for testosterone
He, W., Guo, X., & Zhang, M. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.050 · Cited by 75 · see citing works
Weeks, B. S., Lieberman, D. M., Johnson, B., Roque, E., Green, M., Loewenstein, P. M., Oldfield, E. H., & Kleinman, H. K. (1995) · Journal of Neuroscience Research · doi:10.1002/jnr.490420105 · Cited by 74 · see citing works
Programmed Death‐1: Therapeutic Success after More than 100 Years of Cancer Immunotherapy
Dömling, A. S. S., & Holak, T. A. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307906 · Cited by 72 · see citing works
Han, K., Lee, K.-D., Gao, Z., & Park, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00400-x · Cited by 70 · see citing works
Woitiski, C. B., Carvalho, R. A., Ribeiro, A. J., Neufeld, R. J., & Veiga, F. (2008) · BioDrugs · doi:10.2165/00063030-200822040-00002 · Cited by 69 · see citing works
Polymers for delivering peptides and proteins
Burnham, N. L. (1994) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/51.2.210 · Cited by 68 · see citing works
Naloxegol: A Review of Its Use in Patients with Opioid-Induced Constipation
Garnock-Jones, K. P. (2015) · Drugs · doi:10.1007/s40265-015-0357-2 · Cited by 67 · see citing works
Current and Future Immunomodulation Strategies to Restore Tolerance in Autoimmune DiseasesPreprint
Bluestone, J. A., & Bour-Jordan, H. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007542 · Cited by 65 · see citing works
Airway delivery of peptides and proteins using nanoparticles
Dombu, C. Y., & Betbeder, D. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.08.070 · Cited by 64 · see citing works
Jo, J., Hong, S., Choi, W. Y., & Lee, D. R. (2014) · Scientific Reports · doi:10.1038/srep04378 · Cited by 63 · see citing works
Karagiannis, S. N., Josephs, D. H., Karagiannis, P., Gilbert, A. E., Saul, L., Rudman, S. M., Dodev, T. S., Koers, A., Blower, P. J., Corrigan, C. J., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1162-8 · Cited by 60 · see citing works
Protein Delivery Using Cys 2 –His 2 Zinc-Finger Domains
Gaj, T., Liu, J., Anderson, K. E., Sirk, S. J., & Barbas, C. F. (2014) · ACS Chemical Biology · doi:10.1021/cb500282g · Cited by 60 · see citing works
Zhang, J., Shin, M. C., David, A. E., Zhou, J., Lee, K., He, H., & Yang, V. C.-M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400360q · Cited by 57 · see citing works
Muda, M., Gross, A. W., Dawson, J., He, C., Kurosawa, E., Schweickhardt, R. L., Dugas, M., Soloviev, M., Bernhardt, A., Fischer, D., et al. (2011) · Protein Engineering Design and Selection · doi:10.1093/protein/gzq123 · Cited by 52 · see citing works
Miyaji, Y., Walter, S. A., Chen, L., Kurihara, A., Ishizuka, T., Saito, M., Kawai, K., & Okazaki, O. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040725 · Cited by 46 · see citing works
Gold nanorods in an oil-base formulation for transdermal treatment of type 1 diabetes in mice
Nose, K., Pissuwan, D., Goto, M., Katayama, Y., & Niidome, T. (2012) · Nanoscale · doi:10.1039/c2nr30651d · Cited by 45 · see citing works
A Solvent-Free Thermosponge Nanoparticle Platform for Efficient Delivery of Labile Proteins
Choi, W. I., Kamaly, N., Riol‐Blanco, L., Lee, I.-H., Wu, J., Swami, A., Vilos, C., Yameen, B., Yu, M., Shi, J., et al. (2014) · Nano Letters · doi:10.1021/nl502994y · Cited by 43 · see citing works
Self-citationEnhancing Endosomal Escape of Transduced Proteins by Photochemical Internalisation
Mellert, K., Lamla, M., Scheffzek, K., Wittig, R., & Kaufmann, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052473 · Cited by 42 · see citing works
Lentivirus-Based Virus-Like Particles as a New Protein Delivery Tool
Muratori, C., Bona, R., & Federico, M. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-533-0_7 · Cited by 31 · see citing works
Zhou, P., An, T., Zhao, C., Li, Y., Li, R., Yang, R., Wang, Y., & Gao, X. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.017 · Cited by 27 · see citing works
Magnetic nanoparticles and their applications in image-guided drug delivery
Yu, M. K., Park, J., & Jon, S. (2011) · Drug Delivery and Translational Research · doi:10.1007/s13346-011-0049-8 · Cited by 24 · see citing works
Self-citationToll-Like Receptor 4 Decoy, TOY, Attenuates Gram-Negative Bacterial Sepsis
Jung, K., Lee, J. E., Kim, H.-Z., Kim, H. M., Park, B. S., Hwang, S.-I., Lee, J., Kim, S. C., & Koh, G. Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007403 · Cited by 19 · see citing works
Windisch, M., Wolf, H.-J., Hutter‐Paier, B., & Wronski, R. (2008) · Neurodegenerative Diseases · doi:10.1159/000113707 · Cited by 16 · see citing works
Amphiphilic Polysialic Acid Derivatives: Synthesis, Characterization, and In-Vitro Cytotoxicity
Deepagan, V. G., Thambi, T., Ko, H., Kang, Y. M., & Park, J. H. (2013) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2013.8089 · Cited by 11 · see citing works
Detection of weak receptor–ligand interactions using I g M and J ‐chain‐based fusion proteins
Ammann, J. U., Jahnke, M., Dyson, M. R., Kaufman, J., & Trowsdale, J. (2012) · European Journal of Immunology · doi:10.1002/eji.201142151 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [18]Sassi AB Nagarkar R Hamblin P Novel Approaches and Strategies for Biologics Singh M Salnikova M Vaccines and Cancer Therapies Elsevier Inc 2015 199 217
- [133]Nose K Pissuwan D Goto M Katayama Y Niidome T Gold nanorods in an oil-base formulation for transdermal treatment of type 1 diabetes in mice Nanoscale 4 2012 3776 3780 22622618
Cited by
Sorted by citations
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873 · see citing works
Self-citationEngineered biomaterials for in situ tissue regeneration
Gaharwar, A. K., Singh, I., & Khademhosseini, A. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-0209-x · Cited by 872 · see citing works
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Weiß, C., Carrière, M., Fusco, L., Capua, I., Regla-Nava, J. Á., Matteo Pasquali, A., Scott, J. A., Vitale, F., Ünal, M. A., Mattevi, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03697 · Cited by 603 · see citing works
Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor
Phua, S. Z. F., Yang, G., Lim, W. Q., Verma, A., Chen, H., Thanabalu, T., & Zhao, Y. (2019) · ACS Nano · doi:10.1021/acsnano.9b01087 · Cited by 375 · see citing works
Cheng, G., Li, W., Ha, L., Han, X., Hao, S., Wan, Y., Wang, Z., Dong, F., Zou, X., Mao, Y., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b03584 · Cited by 371 · see citing works
Metal-Organic Framework (MOF)-Based Drug Delivery
Cao, J., Li, X., & Tian, H. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190618152518 · Cited by 282 · see citing works
Rational Design of Nanocarriers for Intracellular Protein Delivery
Qin, X., Yu, C., Wei, J., Li, L., Zhang, C., Wu, Q., Liu, J., Yao, S. Q., & Huang, W. (2019) · Advanced Materials · doi:10.1002/adma.201902791 · Cited by 281 · see citing works
Pramanik, P. K. D., Solanki, A., Debnath, A., Nayyar, A., El–Sappagh, S., & Kwak, K. S. (2020) · IEEE Access · doi:10.1109/access.2020.2984269 · Cited by 221 · see citing works
Iqbal, S., Blenner, M., Alexander-Bryant, A. A., & Larsen, J. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01754 · Cited by 192 · see citing works
Zhang, Q. R., Zhou, Y., Yue, W., Qin, W., Dong, H., & Vasanthan, T. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.01.026 · Cited by 190 · see citing works
Shan, W., Zhu, X. D., Tao, W., Cui, Y., Liu, M., Wu, L., Li, L., Zheng, Y., & Huang, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08183 · Cited by 181 · see citing works
Liposome-based delivery of biological drugs
Magar, K. T., Boafo, G. F., Li, X., Chen, Z., & He, W. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.020 · Cited by 185 · see citing works
Recent advances in colon drug delivery systems
Arévalo-Pérez, R., Maderuelo, C., & Lanao, J. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.026 · Cited by 179 · see citing works
Nanoparticle‐Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis
Jin, Q., Zhu, W., Zhu, J., Zhu, J., Shen, J., Liu, Z., Yang, Y., & Chen, Q. (2021) · Advanced Materials · doi:10.1002/adma.202007557 · Cited by 169 · see citing works
Abbina, S., Vappala, S., Kumar, P., Siren, E. M. J., La, C. C., Abbasi, U., Brooks, D. E., & Kizhakkedathu, J. N. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02515g · Cited by 163 · see citing works
Wu, J., Zheng, Y., Liu, M., Shan, W., Zhang, Z., & Huang, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b16524 · Cited by 154 · see citing works
Self-citationOvercoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
Thomas, O. S., & Weber, W. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00415 · Cited by 138 · see citing works
Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery
Emami, F., Yazdi, S. J. M., & Na, D. H. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00443-1 · Cited by 132 · see citing works
Polymer-based nanoparticles for protein delivery: design, strategies and applications
Zhao, H., Lin, Z. Y., Yildirimer, L., Dhinakar, A., Zhao, X., & Wu, J. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00308g · Cited by 127 · see citing works
Self-citationSilica nanoparticles: A promising platform for enhanced oral delivery of macromolecules
Abeer, M. M., Rewatkar, P. V., Qu, Z., Talekar, M., Kleitz, F., Schmid, R., Lindén, M., Kumeria, T., & Popat, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.021 · Cited by 125 · see citing works
Chen, J., Ouyang, J., Chen, Q., Deng, C., Meng, F., Zhang, J., Cheng, R., Lan, Q., & Zhong, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06879 · Cited by 124 · see citing works
Hollow Nanomaterials in Advanced Drug Delivery Systems: From Single‐ to Multiple Shells
Li, Z., Xu, K., Qin, L., Zhao, D., Yang, N., Wang, D., & Yang, Y. (2022) · Advanced Materials · doi:10.1002/adma.202203890 · Cited by 121 · see citing works
Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120 · see citing works
Kim, M., Sahu, A., Hwang, Y.-M., Kim, G. B., Nam, G., Kim, I., Kwon, I. C., & Tae, G. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119550 · Cited by 119 · see citing works
Polymersome-based protein drug delivery – quo vadis?
Gouveia, M. G., Wesseler, J. P., Ramaekers, J., Weder, C., Scholten, P. B. V., & Bruns, N. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00106c · Cited by 117 · see citing works
Applications of nanogenerators for biomedical engineering and healthcare systems
Wang, W., Pang, J., Su, J., Li, F., Li, Q., Wang, X., Wang, J., Ibarlucea, B., Liu, X., Li, Y., et al. (2021) · InfoMat · doi:10.1002/inf2.12262 · Cited by 118 · see citing works
Advances in nanoparticle-mediated cancer therapeutics: Current research and future perspectives
Deivayanai, V. C., Thamarai, P., Karishma, S., Saravanan, A., Yaashikaa, P. R., Vickram, A. S., Hemavathy, R. V., Kumar, R. R., Rishikesavan, S., & Shruthi, S. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.11.002 · Cited by 114 · see citing works
Song, Z., Chen, X., You, X., Huang, K., Dhinakar, A., Gu, Z., & Wu, J. (2017) · Biomaterials Science · doi:10.1039/c7bm00730b · Cited by 110 · see citing works
Self-citationHe, H., Chen, Y., Li, Y., Song, Z., Zhong, Y., Zhu, R., Cheng, J., & Yin, L. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201706710 · Cited by 110 · see citing works
Nanoparticles as carriers of proteins, peptides and other therapeutic molecules
Pudlarz, A. M., & Szemraj, J. (2018) · Open Life Sciences · doi:10.1515/biol-2018-0035 · Cited by 108 · see citing works
Ding, L., Jiang, Y., Zhang, J., Klok, H., & Zhong, Z. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01664 · Cited by 104 · see citing works
Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals
Zeb, A., Rana, I., Choi, H.-I., Lee, C., Baek, S.-W., Lim, C.-W., Khan, N., Arif, S. T., Sahar, N.-U., Alvi, A. M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121184 · Cited by 104 · see citing works
Chen, J., Zou, Y., Deng, C., Meng, F., Zhang, J., & Zhong, Z. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b04404 · Cited by 99 · see citing works
The therapeutic importance of acid-base balance
Quade, B. N., Parker, M. D., & Occhipinti, R. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114278 · Cited by 103 · see citing works
Deprey, K. L., Becker, L., Kritzer, J. A., & Plückthun, A. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00112 · Cited by 98 · see citing works
Sifniotis, V., Cruz, E., Eroglu, B., & Kayser, V. (2019) · Antibodies · doi:10.3390/antib8020036 · Cited by 99 · see citing works
Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency
Alavi, S. E., Cabot, P. J., & Moyle, P. M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00308 · Cited by 99 · see citing works
Recent progress in polymeric non-invasive insulin delivery
Sabbagh, F., Muhamad, I. I., Niazmand, R., Dikshit, P. K., & Kim, B. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.134 · Cited by 96 · see citing works
Bioperspectives for Shape-Memory Polymers as Shape Programmable, Active Materials
Lendlein, A., Balk, M., Tarazona, N. A., & Gould, O. E. C. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01074 · Cited by 93 · see citing works
Zai, W., Kang, L., Dong, T., Wang, H., Yin, L., Gan, S., Lai, W., Ding, Y., Hu, Y., & Wu, J. (2021) · ACS Nano · doi:10.1021/acsnano.1c07621 · Cited by 97 · see citing works
Self-citationWu, W., Jia, S., Xu, H., Gao, Z., Wang, Z., Lu, B., Ai, Y., Liu, Y., Liu, R., Yang, T., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c12017 · Cited by 92 · see citing works
Allawadhi, P., Singh, V., Govindaraj, K., Khurana, I., Sarode, L. P., Navik, U., Banothu, A. K., Weiskirchen, R., Bharani, K. K., & Khurana, A. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118923 · Cited by 89 · see citing works
Sundaram, M. N., Kaliannagounder, V. K., Selvaprithiviraj, V., Suresh, M. K., Biswas, R., Vasudevan, A. K., Varma, P. K., & Jayakumar, R. (2018) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b00915 · Cited by 88 · see citing works
Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability
Tong, T., Wang, L., You, X., & Wu, J. (2020) · Biomaterials Science · doi:10.1039/d0bm01151g · Cited by 88 · see citing works
Self-citationLi, Y., Yang, T., Yu, Y., Shi, N., Yang, L., Glass, Z., Bolinger, J., Finkel, I. J., Li, W., & Xu, Q. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.011 · Cited by 84 · see citing works
Peng, J., Fumoto, S., Suga, T., Miyamoto, H., Kuroda, N., Kawakami, S., & Nishida, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.021 · Cited by 83 · see citing works
Gonella, A., Grizot, S., Liu, F., Noriega, A. L., & Richard, J. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2105318 · Cited by 82 · see citing works
Faustino, C. M. C., Rijo, P. M., & Reis, C. P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.020 · Cited by 82 · see citing works
Oral delivery of antioxidant enzymes for effective treatment of inflammatory disease
Zeng, Z., He, X. D., Li, C., Lin, S., Chen, H., Liu, L., & Feng, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120753 · Cited by 80 · see citing works
Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy
Han, S., Huang, K., Gu, Z., & Wu, J. (2019) · Nanoscale · doi:10.1039/c9nr08086d · Cited by 79 · see citing works
Self-citationWu, D., Zhou, J., Chen, X., Chen, Y., Hou, S., Qian, H., Zhang, L., Tang, G., Chen, Z., Yuan, P., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119847 · Cited by 79 · see citing works
Recent Advances of Poly(ester amide)s-Based Biomaterials
Han, S., & Wu, J. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00150 · Cited by 76 · see citing works
Self-citationRole of nanostructures in improvising oral medicine
Ghosh, S., Ghosh, S., & Sil, P. C. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.04.004 · Cited by 76 · see citing works
Rashidzadeh, H., Danafar, H., Rahimi, H., Mozafari, F., Salehiabar, M., Rahmati, M.-A., Rahamouz-Haghighi, S., Mousazadeh, N., Mohammadi, A., Ertaş, Y. N., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0441 · Cited by 76 · see citing works
Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles
Li, J., Qiang, H., Yang, W., Xu, Y., Feng, T., Cai, H., Wang, S., Liu, Z., Zhang, Z., & Zhang, J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.020 · Cited by 75 · see citing works
Araújo, F., Shrestha, N., Gomes, M. J., Herranz‐Blanco, B., Liu, D., Hirvonen, J. J., Granja, P. L., Santos, H. A., & Sarmento, B. F. C. C. (2016) · Nanoscale · doi:10.1039/c6nr00294c · Cited by 75 · see citing works
Wang, X., Li, Y., Li, Q., Neufeld, C. I., Pouli, D., Sun, S., Yang, L., Deng, P. J., Wang, M., Georgakoudi, I., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.037 · Cited by 73 · see citing works
Sarıyer, S., Duranoğlu, D., Doğan, Ö., & Küçük, İ. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101551 · Cited by 73 · see citing works
Bukhari, S. N. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040866 · Cited by 74 · see citing works
Batista, P., Castro, P. M., Madureira, A. R., Sarmento, B. F. C. C., & Pintado, M. (2019) · Pharmaceuticals · doi:10.3390/ph12010032 · Cited by 73 · see citing works
Yang, S., Liu, L., Chen, H., Wei, Y., Dai, L., Liu, J., Yuan, F., Mao, L., Li, Z., Chen, F., et al. (2020) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2020.106258 · Cited by 70 · see citing works
Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes
Xiao, Y., Tang, Z., Huang, X., Joseph, J., Chen, W., Chuang, L. I. U., Zhou, J. M., Kong, N., Joshi, N., Du, J., et al. (2021) · Matter · doi:10.1016/j.matt.2021.08.011 · Cited by 69 · see citing works
Protein Nanotherapeutics as an Emerging Modality for Cancer Therapy
Cheng, L., Yang, L., Meng, F., & Zhong, Z. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800685 · Cited by 68 · see citing works
Sustained Release Systems for Delivery of Therapeutic Peptide/Protein
Nie, T., Wang, W., Liu, X., Wang, Y., Li, K., Song, X., Zhang, J., Yu, L., & He, Z. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00160 · Cited by 68 · see citing works
Nanocarriers for oral delivery of biologics: small carriers for big payloads
Cao, Y., Rewatkar, P. V., Wang, R., Hasnain, S. Z., Popat, A., & Kumeria, T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.005 · Cited by 68 · see citing works
Scaling nanopharmaceutical production for personalized medicine: challenges and strategies
Delfino, C. D. S. C., PEREIRA, M. C. D. P., Oliveira, M., Favareto, I. D. C., Valladão, V. S., Mota, M. D. O., Costa, M. V. B., Sousa-Batista, A. J., & Balbino, T. A. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06293-3 · Cited by 68 · see citing works
Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins
Radhakrishnan, K., Nirmal, S., Moreno, M. R., Nirmal, J., Fernandez, A. A., Venkatraman, S. S., & Agrawal, R. V. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.015 · Cited by 66 · see citing works
Rhaman, M. M., Islam, M. R., Akash, S., Mim, M., Noor alam, M., Nepovimova, E., Valis, M., Kuca, K., & Sharma, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.989471 · Cited by 63 · see citing works
Nanomaterials for Protein Delivery in Anticancer Applications
Yau, A., Lee, J., & Chen, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020155 · Cited by 62 · see citing works
Shen, J., Ma, M., Shafiq, M., Yu, H., Lan, Z., & Chen, H. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202113703 · Cited by 62 · see citing works
Huang, K., He, Y., Zhu, Z., Guo, J., Wang, G., Deng, C., & Zhong, Z. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05827 · Cited by 62 · see citing works
Basak, S., Khare, H. A., Roursgaard, M., Kempen, P. J., Lee, J., Bazban‐Shotorbani, S., Kræmer, M. K., Chernyy, S., Andresen, T. L., Almdal, K., et al. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c01238 · Cited by 61 · see citing works
Liu, W., Su, C., Qi, Y., Liang, J., Zhao, L., & Shi, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01425-6 · Cited by 61 · see citing works
The Potential Benefits of Nanotechnology in Treating Alzheimer’s Disease
Ling, T. S., Chandrasegaran, S., Low, Z. X., Suan, T. L., Elaine, E., Nathan, D. V., Chai, Y. H., Gunasekaran, B., & Salvamani, S. (2021) · BioMed Research International · doi:10.1155/2021/5550938 · Cited by 57 · see citing works
Approaches and materials for endocytosis-independent intracellular delivery of proteins
Chen, N., He, Y., Zang, M., Zhang, Y., Lü, H., Zhao, Q., Wang, S., & Gao, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121567 · Cited by 57 · see citing works
Bioorthogonal strategies for site-directed decoration of biomaterials with therapeutic proteins
Braun, A. C., Gutmann, M., Lühmann, T. C., & Meinel, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.018 · Cited by 57 · see citing works
Zwitterionic Janus Dendrimer with distinct functional disparity for enhanced protein delivery
Wang, L., Shi, C., Wang, X., Guo, D., Duncan, T. M., & Luo, J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119233 · Cited by 55 · see citing works
Zhang, Z., Chen, K., Ameduri, B. M., & Chen, M. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00350 · Cited by 55 · see citing works
Zhu, X., Tang, R., Wang, S., Chen, X., Hu, J., Lei, C., Huang, Y., Wang, H., Nie, Z., & Yao, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b09024 · Cited by 55 · see citing works
Nanotraps for the containment and clearance of SARS-CoV-2
Chen, M., Rosenberg, J., Cai, X., Lee, A., Shi, J.-Y., Nguyen, M., Wignakumar, T., Mirle, V. R., Edobor, A., Fung, J. F., et al. (2021) · bioRxiv · doi:10.1016/j.matt.2021.04.005 · Cited by 48 · see citing works
Self-citationKarami, K., Jamshidian, N., Hajiaghasi, A., & Amirghofran, Z. (2020) · New Journal of Chemistry · doi:10.1039/c9nj05847h · Cited by 54 · see citing works
Hypoxic Tumor Radiosensitization Using Engineered Probiotics
Huang, C., Wang, X., Liu, L., Jiang, W., Liu, W., Ma, W., & Zhao, H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002207 · Cited by 54 · see citing works
Biologics and their delivery systems: Trends in myocardial infarction
Borrelli, M. A., Turnquist, H. R., & Little, S. R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.014 · Cited by 53 · see citing works
Designs of metal-organic framework nanoparticles for protein delivery
Kai, M., Wang, S., Gao, W., & Zhang, L. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.056 · Cited by 53 · see citing works
Stimuli-responsive self-assembled dendrimers for oral protein delivery
Zeng, Z., Qi, D., Yang, L., Liu, J., Tang, Y., Chen, H., & Feng, X. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.049 · Cited by 53 · see citing works
The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers
Shrestha, N., Bouttefeux, O., Vanvarenberg, K., Lundquist, P., Cuñarro, J., Tovar, S. A., Khodus, G. R., Andersson, E., Keita, Å. V., Dieguez, C. G., et al. (2017) · Nanoscale · doi:10.1039/c7nr07736j · Cited by 51 · see citing works
Zheng, F., Wang, C., Meng, T., Zhang, Y., Zhang, P., Shen, Q., Zhang, Y., Zhang, J., Li, J., Min, Q., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b03424 · Cited by 51 · see citing works
Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives
Zhang, J., Wang, L., You, X., Xian, T., Wu, J., & Pang, J. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190125145836 · Cited by 50 · see citing works
Self-citationChen, J., He, H., Deng, C., Yin, L., & Zhong, Z. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.040 · Cited by 50 · see citing works
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials
Hassanzadeh, P. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.060 · Cited by 48 · see citing works
Sikder, A., Chakraborty, S., Rajdev, P., Dey, P., & Ghosh, S. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00195 · Cited by 48 · see citing works
Frizzell, H., Ohlsen, T. J., & Woodrow, K. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.043 · Cited by 48 · see citing works
Zhang, X., Zhang, R., Huang, J. C., Luo, M., Chen, X., Kang, Y., & Wu, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00181f · Cited by 48 · see citing works
Self-citationChen, S., Pang, H., Sun, J., & Li, K. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm01020a · Cited by 47 · see citing works
Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions
Sivasankaran, R. P., Snell, K., Kunkel, G. E., Georgiou, P. G., Puente, E. G., & Maynard, H. D. (2024) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2024.101867 · Cited by 49 · see citing works
Design and applications of protein delivery systems in nanomedicine and tissue engineering
Bizeau, J., & Mertz, D. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102334 · Cited by 47 · see citing works
Leconet, W., Liu, H., Guo, M., Lamer-Déchamps, S. L., Molinier, C., Kim, S., Vrlinič, T., Oster, M., Liu, F., Navarro, V., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1138 · Cited by 46 · see citing works
Yao, P., Zhang, Y., Meng, H., Sun, H., & Zhong, Z. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b01243 · Cited by 46 · see citing works
Lipid Nanoparticle Delivery of Small Proteins for Potent In Vivo RAS Inhibition
Haley, R. M., Chan, A., Billingsley, M. M., Gong, N., Padilla, M. S., Kim, E. H., Wang, H. H., Yin, D., Wangensteen, K. J., Tsourkas, A., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c01501 · Cited by 43 · see citing works
Enzymes as key features in therapeutic cell mimicry
Itel, F., Schattling, P., Zhang, Y., & Städler, B. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.006 · Cited by 45 · see citing works
- Authors
- Yu, M., Wu, J., Shi, J., & Farokhzad, O. C.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Shi, Jinjun
- Farokhzad, Omid C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 240
- Pages
- 24-37
- ISSN
- 0168-3659 (ISSN-L)
- PMC
- PMC4833694
- OpenAlex
- W2173147935
- Cited by
- 410
- References
- 138
- Citations by year
- 2026: 29 · 2025: 47 · 2024: 34 · 2023: 40 · 2022: 44 · 2021: 65 · 2020: 47 · 2019: 48 · 2018: 26 · 2017: 21 · 2016: 9
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- National Institutes of Health (NIH) (EB015419, R00CA160350, U54-CA151884)
- Movember-Prostate Cancer Foundation (PCF)
- National Research Foundation of Korea (K1A1A2048701)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- protein delivery, nanotechnology, therapeutic proteins, nanoparticle drug delivery, systemic drug delivery, intracellular delivery, endosomal escape, membrane permeability, protein stability, immunogenicity, oral drug delivery, intranasal drug delivery, pulmonary drug delivery, transdermal drug delivery
- MeSH terms
- Animals, Humans, Proteins, Tissue Distribution, Drug Delivery Systems, Nanotechnology, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review